Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.

BACK TO LIST

Patient
Name:	Harrison, , Roy,
DOB:	02-OCT-1969 (Age: 56)
Gender:	male
Address:	Flat 4 Dyer route BA1 Baileyville (United Kingdom)
ID:	7093-553922-4 (ECI)

Report
Date:	01-MAR-2016

Laboratory
dr Ample, Ex Laboratoire Central Européenne Boulevard du Jardin Botanique 32 1000 Brussels (Belgium)

Requested by
Evelina Children's Hospital SE1 7 London (United Kingdom)

Specimen
Collected:	01-MAR-2016

Hematology

Test	01-MAR-2016	Reference Range	Unit
Leukocytes [#/volume] in Blood by Automated count	10.2	3.4 - 10.6	10*3/uL
Erythrocytes [#/volume] in Blood by Automated count	4.4 L	4.5 - 6.2	10*6/uL
Hemoglobin [Mass/volume] in Blood	17.1	13.5 - 17.5	g/dL
Hematocrit [Volume Fraction] of Blood by Automated count	44.4	38 - 50	%
MCV [Entitic volume] by Automated count	92.6	80 - 105	fL
MCH [Entitic mass] by Automated count	32.8	27 - 34	pg
MCHC [Mass/volume] by Automated count	33.1	31.5 - 36	g/dL
Erythrocyte distribution width [Entitic volume] by Automated count	41.7	36 - 55	fL
Platelets [#/volume] in Blood by Automated count	178.6	150 - 450	10*3/uL
Platelet distribution width [Entitic volume] in Blood by Automated count	243.5 H	13.4 - 17.4	fL
Platelet mean volume [Entitic volume] in Blood by Automated count	9.4 L	9.8 - 13.8	fL

Chemistry

Test	01-MAR-2016	Reference Range	Unit
Hemoglobin A1c/Hemoglobin.total in Blood	7.0 H	4.6 - 6	%
Glucose [Mass/volume] in Blood	116.8 H	70 - 99	mg/dL
Urea nitrogen [Mass/volume] in Blood	16.8	7 - 50	mg/dL
Creatinine [Mass/volume] in Blood	1.2	0.9 - 1.3	mg/dL
Calcium [Mass/volume] in Blood	10.1	8.5 - 10.5	mg/dL
Sodium [Moles/volume] in Blood	136.3	135 - 145	mmol/L
Potassium [Moles/volume] in Blood	4.0	3.5 - 5.1	mmol/L
Chloride [Moles/volume] in Blood	107.5	98 - 114	mmol/L
Carbon dioxide, total [Moles/volume] in Blood	28.5	22 - 32	mmol/L
Cholesterol [Mass/volume] in Serum or Plasma	216.6 H	125 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	178.5 H	0 - 150	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	134.4 H	0 - 130	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	46.5	40 - 60	mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine	11.9	0 - 30	mg/g

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The results indicate poor glycemic control (elevated HbA1c and fasting glucose), dyslipidemia (high total cholesterol, LDL, and triglycerides), and mild erythrocytopenia. Renal function and microalbuminuria are within normal limits. Platelet indices show mild abnormalities but are not critical. These findings are consistent with metabolic syndrome and increased cardiovascular risk; clinical correlation and management optimization are recommended.

Conclusion and Recommendations based on this report and previous findings known to us

The results indicate poor glycemic control (elevated HbA1c and fasting glucose), dyslipidemia (high total cholesterol, LDL, and triglycerides), and mild erythrocytopenia. Renal function and microalbuminuria are within normal limits. Platelet indices show mild abnormalities but are not critical. These findings are consistent with metabolic syndrome and increased cardiovascular risk; clinical correlation and management optimization are recommended.